Discontinuation report INDIGO CARMINE
| Report ID | 135291 |
| Drug Identification Number | 02014815 |
| Brand name | INDIGO CARMINE |
| Common or Proper name | Indigolindisulronate Sodium Injection |
| Company Name | AKORN INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | INDIGO CARMINE |
| Strength(s) | 0.8% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 5 mL ampule |
| ATC code | V04CH |
| ATC description | OTHER DIAGNOSTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2021-03-01 |
| Remaining supply date | 2012-11-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1925 WEST FIELD CT LAKE FOREST, ILLINOIS UNITED STATES 60045 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2021-03-08 | French | Compare |
| v2 | 2021-03-08 | English | Compare |
| v1 | 2021-03-08 | English | Compare |
Showing 1 to 3 of 3